Sort by
Refine Your Search
-
(BDCL), within the Nutritional Biomarkers Branch (NBB), Division of Laboratory Sciences (DLS), National Center for Environmental Health (NCEH), develops and applies analytical methods for measuring
-
the quantitation of water-soluble biomarkers (e.g., vitamins B1, B2, and B6, methylmalonic acid) in serum, plasma, or whole blood matrices. Analytical method development and validation: You may gain experience in
-
laboratory quality management activities, including method documentation, quality control, specimen management, and laboratory safety. Preparing and delivering scientific findings through informal and formal
-
analyses for methods such as flow cytometry, cell culture/stimulations, and RNA sequencing (bulk, single-cell, spatial) may also be available based on your interests. Research endeavors are intrinsically
-
opportunities to interpret and communicate research findings. Exposure to additional assays and analyses for methods such as flow cytometry, cell culture/stimulations, and RNA sequencing (bulk, single-cell
-
, especially those planning to pursue a future PhD, DVM, or MD. Learning Objectives: Under the guidance of a mentor and in close collaboration with senior laboratory personnel, you will have the opportunity
-
scientific methods and analytical approaches used to support the mission of the ATSDR Office of Innovation and Analytics (OIA). You will gain hands-on experience with computational, data science, and other
-
Project: This project at the Food Safety and Enteric Pathogens Research Unit is focused on identifying methods to reduce Shiga toxin-producing Escherichia coli in food producing animals. Under the guidance
-
organizational goals. Designing and implementing a public health program evaluation using quantitative and qualitative data analysis methods. Reporting evaluation results using data visualization techniques
-
trials, multiple endpoints, adaptive designs, Bayesian design and analysis methods, estimands, meta-analyses, benefit-risk analyses, subgroup analyses, biosimilars, patient experience data, bioequivalence